Group 1 - The core viewpoint of the news is that the Chengxi Science and Technology Innovation Corridor is experiencing significant growth in industrial value added, particularly in the digital economy sector, which reached 1400.3 billion yuan with a growth rate of 10.6% in the first half of the year [1] - The corridor is focusing on "reform empowerment and innovation deepening," aiming for high-quality integrated development through improved transportation networks and talent innovation mechanisms [1][2] - The corridor has added 5,199 high-level talents in the first half of the year, accounting for 25.7% of the city's new talent, and is promoting collaboration between schools and research institutions to accelerate the commercialization of scientific achievements [1][2] Group 2 - The corridor is set to strengthen its artificial intelligence industry, focusing on key areas such as AI models, intelligent computing, and humanoid robots, while also planning to establish a national-level brain-like computing industry pilot zone [2] - To enhance the integration of technology and finance, the corridor will implement innovative financial policies to support the transformation of scientific achievements and the upgrading of industries, particularly for small and medium-sized technology enterprises [2] - The Chengxi Science and Technology Innovation Corridor aims to deepen the integration of education, technology, and talent development, positioning itself as a key driver of technological innovation in the province [3]

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：688046 证券简称：药康生物 公告编号：2025-014 江苏集萃药康生物科技股份有限公司 关于使用闲置自有资金 进行委托理财的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性依法承担法律责任。 江苏集萃药康生物科技股份有限公司（以下简称"公司"）于 2025 年 4 月 7 日召开第二届董事会第十次 会议、第二届监事会第九次会议，审议了《关于使用闲置自有资金进行委托理财的议案》，一致同意公 司在不影响正常经营的情况下，使用不超过人民币 7 亿元（含本数）自有闲置资金进行委托理财，有效 期自董事会审议通过之日起至下一年度董事会审议使用闲置自有资金进行委托理财事项之日止，如单笔 交易的有效期超过决议的有效期，则决议的有效期自动顺延至单笔交易终止时止。在上述额度及有效期 内，资金可循环滚动使用。董事会授权总经理或其授权人士行使投资决策权并签署相关法律文件，由公 司财务部及资金部具体实施相关事宜，本事项无需提交公司股东大会审议。现将相关情况公告如下： 一、使用闲置自有资金进行委托 ...